Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Trials
|
October 8, 2022
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
Julia M Neuhann, Jannik Stemler, Antonio Carcas, et al.
BMC Medical Research Methodology
|
August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Statistics in Medicine
|
February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional Hazards
Florian Klinglmüller, Tobias Fellinger, Franz König, et al.
Transfusion Medicine (Oxford, England)
|
May 31, 2021
The impact of the SARS-CoV-2 pandemic on the ongoing prospective, international, multicentre observational study assessing the preoperative anaemia prevalence in surgical patients (ALICE-trial)
Leonie Judd, David M Baron, Elvira Bisbe, et al.
American Journal of Cancer Research
|
May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells
Thomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Orphanet Journal of Rare Diseases
|
November 17, 2018
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Caridad Pontes, Juan Manuel Fontanet, Roser Vives, et al.
Pharmaceutical Statistics
|
March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873
Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Statistical Methods in Medical Research
|
April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic review
Maximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Intensive Care Medicine
|
October 9, 2023
The impact of religion on changes in end-of-life practices in European intensive care units: a comparative analysis over 16 years
Joerg C Schefold, Livio Ruzzante, Charles L Sprung, et al.
Nature Medicine
|
February 2, 2023
Implementing clinical trial data sharing requires training a new generation of biomedical researchers
Ulrich Mansmann, Clara Locher, Fabian Prasser, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Trials
|
October 8, 2022
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
Julia M Neuhann, Jannik Stemler, Antonio Carcas, et al.
BMC Medical Research Methodology
|
August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Statistics in Medicine
|
February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional Hazards
Florian Klinglmüller, Tobias Fellinger, Franz König, et al.
Transfusion Medicine (Oxford, England)
|
May 31, 2021
The impact of the SARS-CoV-2 pandemic on the ongoing prospective, international, multicentre observational study assessing the preoperative anaemia prevalence in surgical patients (ALICE-trial)
Leonie Judd, David M Baron, Elvira Bisbe, et al.
American Journal of Cancer Research
|
May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells
Thomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Orphanet Journal of Rare Diseases
|
November 17, 2018
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Caridad Pontes, Juan Manuel Fontanet, Roser Vives, et al.
Pharmaceutical Statistics
|
March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873
Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Statistical Methods in Medical Research
|
April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic review
Maximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Intensive Care Medicine
|
October 9, 2023
The impact of religion on changes in end-of-life practices in European intensive care units: a comparative analysis over 16 years
Joerg C Schefold, Livio Ruzzante, Charles L Sprung, et al.
Nature Medicine
|
February 2, 2023
Implementing clinical trial data sharing requires training a new generation of biomedical researchers
Ulrich Mansmann, Clara Locher, Fabian Prasser, et al.
Page
of 17